eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Nurse-delivered WRITE Symptoms© vs. self-directed WRITE Symptoms© vs. care as usual for optimal symptom management for women with recurrent ovarian, fallopian tube, or primary peritoneal cancer

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-de1b-4af7-9953-50a980000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://www.clinicaltrials.gov/ct2/show/NCT00958698
  2. Intervention
    Written Representational Intervention To Ease (WRITE) symptom management program
  3. Intervention
    Assessment of therapy complications
  4. Intervention
    Management of therapy complications
  5. Intervention
    Psychosocial assessment and care
  6. Intervention
    Quality-of-life assessment
  7. Intervention
    Educational intervention
  8. Intervention
    Internet-based intervention
  9. Intervention
    Questionnaire administration
  10. Intervention
    Communication intervention
  11. Additional Topic(s)
    Psychosocial Effects of Cancer and Its Treatment
  12. Additional Topic(s)
    Symptom management
  13. Resource Description
    "This randomized clinical trial is studying two different symptom management programs to see how well they work compared with usual care in patients with recurrent or persistent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer."
  14. Additional Name
    Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
  15. Contact
    Berenberg, Jeffrey
  16. PI
    Wilkinson, Robert, M.D.
  17. Topic
    peritoneal carcinoma
  18. Topic
    fallopian tube cancer
  19. Topic
    ovarian cancer
  20. Study Population
    Females 18 years and older Diagnosis of ovarian, fallopian tube, or primary peritoneal cancer that has recurred or persisted following primary therapy, and meeting other symptom-related criteria
  21. Funded by
    Gynecologic Oncology Group
  22. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016